Periodic Reporting for period 1 - ICG68-PROG (Imaging of c-Met aberrant cancers with Gallium-68 chelators for positron emission tomography)

Aberrant hepatocyte growth factor/hepatocyte growth factor receptor (HGFR or c-Met) signalling is involved in the development of several tumor types. Monitoring of c-Met expression in real time will assist in the diagnosis and in the monitoring of response to therapy. The...